CHIME – an HCV microelimination project based on tailored screening and treatment of PWIDs on opioid agonist therapy in Vienna

Caroline Schwarz, R. Schubert,Michael Schwarz, Alexander Schütz, Andreas Jenke,David JM Bauer, B. Steinwender,E Gutic,Thomas Reiberger,Hans Haltmayer,Michael Gschwantler

Zeitschrift Fur Gastroenterologie（2023）

引用 0|浏览6

暂无评分

摘要

Background Despite the availability of modern direct-acting antiviral (DAA) treatment regimens, the prevalence of chronic hepatitis C remains high among people who inject drugs (PWIDs). Through the CHIME project, individualized HCV screening and treatment were offered to 6,665 PWIDs on opioid agonist therapy (OAT) in Vienna.

查看译文

关键词

opioid agonist therapy,hcv microelimination project,pwids

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要